With regard to the National Pharmacare Program: (a) what is the average cost since the program's inception, broken down by patient and year; (b) what is the projected average cost for each of the next five fiscal years, broken down by patient and year; (c) what is the total number of prescription drug claims submitted to date, including a breakdown by province; (d) what is the number of claims that have been denied, along with a breakdown of the reasons for denial; and (e) what is the total administrative cost of delivering the National Pharmacare Program since its inception, including payments to third-party administrators and technology platforms?
In the House of Commons on September 15th, 2025. See this statement in context.